US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.80

+0.02710.08%

Post-market: 33.77-0.0271-0.08%16:10 EDT

Volume:222

Turnover:8K

Market Cap:13.52M

PE:- -

High:33.80

Open:33.77

Low:33.80

Close:33.77

52wk High:34.98

52wk Low:27.25

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.14

T/O Rate:0.06%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Johnson & Johnson (JNJ) Gets a Buy from Scotiabank

Changchun High-Tech's GenSci136 Injection Receives Approval for Domestic Clinical Trial Application

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Merck in License Pact Worth up to $2.13 Billion with SciBrunch Therapeutics

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Merck enters global license agreement with SciBrunch Therapeutics for SPR2015

Merck Enters into Exclusive Global License Agreement with Scibrunch Therapeutics for Spr2015, an Investigational Oral Kras G12d (On) Inhibitor

Merck & Co - to Record $400 Mln Pre-Tax Charge, $0.13 Per Share, in Q3 2026

THOMSON REUTERS

Merck & Co - Deal Includes $400 Mln Upfront, Total Potential Value $2.13 Bln; Deal Closed

THOMSON REUTERS

Merck & Co Inc: Under Agreement, Scibrunch Granted Co Exclusive Rights to Develop, Manufacture & Commercialize Spr2015 Worldwide

THOMSON REUTERS

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

Sun-Novo Pharmaceutical's STC008 Injection Meets Expected Goals in Phase I Trial for Cancer Cachexia in Advanced Solid Tumors

Betta Pharmaceuticals (300558.SZ): BPI-572270 Capsules Approved for Clinical Trials in Australia

Wuhan Hiteck Biological Pharma Secures Clinical Trial Approval for Epranemide Injection

Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection

Merck's Keytruda Subcutaneous Formulation Approved for Launch in China

Ingenia Therapeutics Expects USD 5 Million MK-8748 Milestone Payment from Merck Unit Eyebiotech

EBR Systems advances FDA approval process for new WiSE manufacturing site

Sichuan Biokin Pharmaceutical Receives Clinical Trial Approval for Injectable BL-M12D1 (ADC)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BMED/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.7958,"timestamp":1790971200000,"preClose":33.7687,"halted":0,"volume":222,"hourTrading":{"tag":"盘后","latestPrice":33.7687,"preClose":33.7958,"latestTime":"16:10 EDT","volume":6,"amount":202.7748,"timestamp":1790971804491,"change":-0.0271,"changeRate":-0.000802,"amplitude":0},"delay":0,"changeRate":0.0008025183083742411,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Market Closed","change":0.0271,"latestTime":"10-02 16:00:00 EDT","open":33.7687,"high":33.7958,"low":33.7958,"amount":7529,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":33.7687,"sharesOutstanding":360000,"nav":33.765684,"aum":13506273.6,"dividendRate":0.002361,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.7687,"preClose":33.7958,"latestTime":"16:10 EDT","volume":6,"amount":202.7748,"timestamp":1790971804491,"change":-0.0271,"changeRate":-0.000802,"amplitude":0},"volumeRatio":0.13654815922563465,"impliedVol":0.2698,"impliedVolPercentile":0.7331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.13654815922563465,"shares":400000,"dividePrice":0.0798,"high":33.7958,"amplitude":0,"preClose":33.7687,"low":33.7958,"week52Low":27.25,"pbRate":"--","week52High":34.98,"institutionHeld":0,"latestPrice":33.7958,"eps":0,"divideRate":0.002361,"volume":222,"delay":0,"ttmEps":0,"open":33.7687,"prevYearClose":30.32,"prevWeekClose":34.7637,"prevMonthClose":34.561,"prevQuarterClose":34.561,"fiveDayClose":34.7637,"twentyDayClose":34.42,"sixtyDayClose":31.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670025382","title":"Johnson & Johnson (JNJ) Gets a Buy from Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2670025382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670025382?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:55","pubTimestamp":1790603740,"startTime":"0","endTime":"0","summary":"Scotiabank analyst Louise Chen maintained a Buy rating on Johnson & Johnson today and set a price target of $305.00. According to TipRanks, Chen is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/johnson-johnson-jnj-gets-a-buy-from-scotiabank-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/johnson-johnson-jnj-gets-a-buy-from-scotiabank-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1043141396.HKD","LU1894683264.USD","LU1551013425.SGD","XLV","BMED","LU1983299246.USD","RXL","LU1032955483.USD","JNJ","IE0001KFT4U8.USD","LU1778281490.HKD","MEDX","LU1162221912.USD","LU2347655156.SGD","PJP","LU1145028129.USD","LU1430594728.SGD","LU1989771016.USD","IE000BZT7R73.USD","GDOC","LU1280957306.USD","FTXH","LU2403377893.USD","LU0053666078.USD","FHLC","LU0787776722.HKD","IE00BJT1NW94.SGD","LU1032466523.USD","LU1061106388.HKD","LU2750360997.AUD","JDOC","LU0912757837.SGD","BK4581","VHT","LU2471134952.CNY","LU0994945656.USD","IE0000B7K699.USD","IHE","LU2468319806.SGD","IE00BN8TJ469.HKD","LU2471134796.USD","LU2133065610.SGD","TRUH","IE0009355771.USD","IXJ","IYH","LU1244550221.USD","LU2430703251.USD","IE00BJJMRZ35.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191494287","title":"Changchun High-Tech's GenSci136 Injection Receives Approval for Domestic Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1191494287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191494287?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:36","pubTimestamp":1790595380,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) has announced that its subsidiary, Changchun GeneScience Pharmaceutical Co., Ltd. (\"GeneScience Pharmaceutical\"), has received a Drug...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0075","BK0239","000661","BK0046","PSYK","BK0057","BK0188","BMED","IBBJ","IBBQ","MDTX","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2087621335.USD","LU1066053197.SGD","MEDI","SG9999015952.SGD","LU1839511570.USD","LU0965509283.SGD","TBXU","TMED","IE00BKPKM429.USD","SG9999014021.USD","LU2468319806.SGD","LU2210150020.SGD","BMED","LU1066051498.USD","SG9999014013.SGD","IBBQ","LU1934455277.USD","IE00B3QW5Z07.USD","BCDF","LU0965509101.SGD","LU0823416689.USD","LU1037948897.HKD","IE00BN0W2V16.EUR","BK4568","IE00B3T34201.USD","IE00BQXX3C00.GBP","LU0859254822.USD","LU0861579265.USD","BK4583","LU1934455863.HKD","BK4566","LU1571399168.USD","BIB","GILD","LU0234570918.USD","IE00B19Z3581.USD","NDAQ","BK4532","IE00BN0W2W23.USD","LU1061106388.HKD","IBB","LU2112291526.USD","BBH","LU2210149790.SGD","SG9999015978.USD","XLO","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234567","title":"U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234567","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234567?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595000,"startTime":"0","endTime":"0","summary":"NDA submission completed following positive Phase 3 SELVA results; potential U.S. commercial launch in the first half of 2027, if approved QTORIN rapamycin has the potential to become the first FDA-ap","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369784/0/en/u-s-food-and-drug-administration-awards-additional-funding-for-qtorin-rapamycin-for-the-treatment-of-microcystic-lymphatic-malformations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LABU","BMED","HYLG","BK4585","GDOC","IDNA","BK4588","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670400231","title":"Merck in License Pact Worth up to $2.13 Billion with SciBrunch Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2670400231","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670400231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:23","pubTimestamp":1790594580,"startTime":"0","endTime":"0","summary":"Merck & Co. has agreed to license a potential cancer treatment from SciBrunch Therapeutics in a deal that could be worth more than $2 billion to the privately held clinical-stage biotechnology company.Merck on Monday said the agreement gives the Rahway, N.J., drugmaker exclusive worldwide rights to develop, manufacture and commercialize SPR2015, an engineered inhibitor for one of the most prevalent mutant forms of the KRAS gene found in human cancers.Merck said it is making a $400 million upfront payment to SciBrunch. The  clinical-stage biotech company is also eligible to receive milestone payments associated to development, commercialization and other activities across multiple indications that could bring the total potential value of the transaction to $2.13 billion.Merck said it will record a pretax charge of $400 million, or about 13 cents a share, in the third quarter related to the transaction, which has closed.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Merck in License Pact Worth up to $2.13 Billion with SciBrunch Therapeutics","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","LU1699723380.USD","VHT","LU2125909247.SGD","BK4007","LU1057294990.SGD","LU2461242641.AUD","LU1032466523.USD","IE00BSNM7G36.USD","LU1989772923.USD","LU0320765489.SGD","LU1917777945.USD","LU0861579265.USD","LU0942090050.USD","LU1974910355.USD","LU1291159041.SGD","LU1023059063.AUD","SG9999015341.SGD","LU1989771016.USD","LU1116320737.USD","LU1116320901.HKD","LU2112291526.USD","SG9999014567.USD","LU1093756168.USD","SG9999001440.SGD","LU0070302665.USD","BMED","LU2357627491.SGD","LU0124676726.USD","SG9999015358.SGD","LU0069063385.USD","BK4533","JDOC","LU1585245621.USD","LU1941712264.USD","LU0203345920.USD","LU1934455863.HKD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0965508806.USD","LU2360032135.SGD","LU0289739699.SGD","BK4559","LU0238689110.USD","LU1923622614.USD","LU1037948541.HKD","LU2023250504.SGD","IE0002141913.USD","IE00B2B36J28.USD","GDOC","LU1037948897.HKD","LU1093756325.SGD","SG9999014559.SGD","LU0130102774.USD","LU0122379950.USD","LU2125909593.SGD","BK4550","LU0689626769.HKD","BK4534","LU1066051225.USD","SG9999001176.SGD","BK4588","LU0266013472.USD","LU0472753341.HKD","LU1066051498.USD","LU1929549753.HKD","LU0106261372.USD","LU0648001328.SGD","IE00BLSP4452.SGD","LU0965509010.AUD","LU2491049909.HKD","SG9999013999.USD","LU0098860793.USD","IE00BJJMRZ35.SGD","LU2361045086.USD","SG9999002232.USD","TRUH","IE00B1BXHZ80.USD","LU0985320562.USD","HRTS","LU1035773651.USD","SG9999001176.USD","LU2106854487.HKD","LU2089984988.USD","LU0208291251.USD","LU1061106388.HKD","PAWZ","LU0162691827.USD","SG9999014575.USD","LU0868494708.USD","LU2324357040.USD","LU2125154778.USD","LU0477156953.USD","LU0511384066.AUD","LU2023250843.SGD","FTXH","IE000M9KFDE8.USD","LU0265550946.USD","LU1941712348.USD","LU2361044949.HKD","LU0072461881.USD","LU1066051811.HKD","BK4516","LU2125154935.USD","FHLC","LU0058720904.USD","SG9999014542.SGD","IHE","IXJ","XLV","LU1983299246.USD","LU1069347547.HKD","LU0289961442.SGD","MRK","LU2361044865.SGD","LU1066053197.SGD","LU0057025933.USD","IE00BN8TJ469.HKD","RXL","LU0203347892.USD","LU0859254822.USD","LU1571399168.USD","SGXZ57979304.SGD","PPH","IE00B4R5TH58.HKD","LU2468319806.SGD","IE0009355771.USD","LU1934455277.USD","LU0130517989.USD","IE00BJT1NW94.SGD","LU0211331839.USD","IE00BLSP4239.USD","LU2491050071.SGD","LU1430594728.SGD","LU0868494617.USD","LU0265550359.USD","LU0006306889.USD","LU1989772840.SGD","LU0320765646.SGD","LU1934455194.USD","LU0965509283.SGD","LU2433249047.HKD","LU1201861249.SGD","LU0980610538.SGD","LU1162221912.USD","LU2491050154.USD","LU0965509101.SGD","IYH","IE00BBT3K403.USD","SG9999002224.SGD","LU0432979614.USD","LU0234572021.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670313352","title":"Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2670313352","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670313352?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:00","pubTimestamp":1790593200,"startTime":"0","endTime":"0","summary":"–Pooled analysis of five clinical trials found no clinical or subclinical evidence of cardiotoxicity at cumulative doses exceeding traditional anthracycline limits –Independent Cleveland Clinic cardio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369741/0/en/moleculin-announces-publication-of-peer-reviewed-cardiac-safety-analysis-of-annamycin-in-frontiers-in-cardiovascular-medicine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","GDOC","NVIB","CSII","HYLG","BMED","MEDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239208","title":"Merck enters global license agreement with SciBrunch Therapeutics for SPR2015","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239208","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239208?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592656,"startTime":"0","endTime":"0","summary":"Merck (MRK) and SciBrunch Therapeutics announced that they have entered into an exclusive global license agreement for SPR2015, an investigational ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-enters-global-license-agreement-with-scibrunch-therapeutics-for-spr2015-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-enters-global-license-agreement-with-scibrunch-therapeutics-for-spr2015-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","IE00BSNM7G36.USD","LU2125909247.SGD","LU0511384066.AUD","LU0965509010.AUD","LU2324357040.USD","HRTS","LU1032466523.USD","LU1934455863.HKD","LU0106261372.USD","LU0868494708.USD","BMED","LU1066051498.USD","LU0208291251.USD","BK4559","LU1989771016.USD","LU0689626769.HKD","LU1929549753.HKD","IE0002141913.USD","IE000M9KFDE8.USD","LU0238689110.USD","IE00B2B36J28.USD","LU0203347892.USD","LU0472753341.HKD","LU1989772840.SGD","LU2112291526.USD","SG9999014567.USD","LU1023059063.AUD","LU0265550359.USD","LU0162691827.USD","FTXH","BK4533","LU0057025933.USD","LU1066051225.USD","LU0980610538.SGD","LU0266013472.USD","LU1585245621.USD","LU1571399168.USD","LU1037948897.HKD","LU0265550946.USD","IE00BJJMRZ35.SGD","LU1066051811.HKD","LU2106854487.HKD","LU0124676726.USD","LU2361044865.SGD","BK4007","SG9999014575.USD","LU0211331839.USD","IE00BLSP4239.USD","SG9999001176.USD","SG9999002232.USD","LU0868494617.USD","SG9999013999.USD","BK4585","LU2125154935.USD","SG9999015358.SGD","LU0477156953.USD","VHT","LU1934455194.USD","LU1983299246.USD","LU2125154778.USD","LU0203345920.USD","LU1989772923.USD","LU1430594728.SGD","JDOC","IE0009355771.USD","LU1037948541.HKD","LU0234572021.USD","SG9999001176.SGD","LU0861579265.USD","XLV","LU1923622614.USD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","LU0072461881.USD","LU0289739699.SGD","PPH","SG9999014542.SGD","LU2360032135.SGD","LU1093756325.SGD","FHLC","LU2468319806.SGD","MRK","LU1917777945.USD","LU2125909593.SGD","LU1116320901.HKD","BK4534","LU2433249047.HKD","LU1035773651.USD","LU0985320562.USD","LU1941712264.USD","BK4516","IE00BLSP4452.SGD","LU2357627491.SGD","LU0965509283.SGD","LU0289961442.SGD","LU0289739343.SGD","LU0859254822.USD","LU0006306889.USD","LU1162221912.USD","LU1066053197.SGD","SG9999015341.SGD","LU1699723380.USD","LU0058720904.USD","LU0823416689.USD","LU0965508806.USD","IE00BBT3K403.USD","LU0942090050.USD","LU0320765646.SGD","LU2023250843.SGD","LU1061106388.HKD","LU2089984988.USD","GDOC","LU2361044949.HKD","SG9999002224.SGD","SG9999014559.SGD","LU1093756168.USD","LU0130517989.USD","LU0320765489.SGD","LU2491050154.USD","LU0432979614.USD","LU1934455277.USD","IE00B1BXHZ80.USD","LU1116320737.USD","LU2461242641.AUD","LU0122379950.USD","LU0070302665.USD","LU2491050071.SGD","LU1974910355.USD","SGXZ57979304.SGD","IYH","SG9999001440.SGD","LU0130102774.USD","LU1291159041.SGD","RXL","BK4550","TRUH","LU2023250504.SGD","PAWZ","LU1941712348.USD","LU2361045086.USD","LU2491049909.HKD","LU0965509101.SGD","LU1201861249.SGD","IHE","LU0098860793.USD","IE00BJT1NW94.SGD","IXJ","IE00BN8TJ469.HKD","LU0069063385.USD","LU1069347547.HKD","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670223969","title":"Merck Enters into Exclusive Global License Agreement with Scibrunch Therapeutics for Spr2015, an Investigational Oral Kras G12d (On) Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2670223969","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670223969?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:46","pubTimestamp":1790592392,"startTime":"0","endTime":"0","summary":"BRIEF-Merck Enters Into Exclusive Global License Agreement With Scibrunch Therapeutics For Spr2015, An Investigational Oral Kras G12d (On) InhibitorSept 28 (Reuters)-Merck & Co IncMRK.N:MERCK ENTERS I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUABQXML8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","BK4550","LU1989772923.USD","SG9999001176.SGD","LU1291159041.SGD","RXL","LU0162691827.USD","LU1162221912.USD","LU1941712264.USD","LU1066051811.HKD","LU2324357040.USD","LU2357627491.SGD","LU1093756325.SGD","LU0265550359.USD","LU2361044865.SGD","BK4588","XLV","LU0985320562.USD","BK4516","PPH","LU2360032135.SGD","IE0002141913.USD","SG9999014567.USD","FTXH","LU2491049909.HKD","LU0965509101.SGD","LU1069347547.HKD","VHT","IE0009355771.USD","LU2023250504.SGD","BK4585","LU0289739343.SGD","LU0823416689.USD","SG9999013999.USD","GDOC","LU0058720904.USD","IE00BLSP4452.SGD","LU0124676726.USD","LU0069063385.USD","BK4534","LU0072461881.USD","LU1057294990.SGD","LU1585245621.USD","LU1061106388.HKD","SG9999014542.SGD","SG9999014575.USD","BK4559","LU2491050154.USD","LU2361045086.USD","LU0234572021.USD","LU1116320901.HKD","LU0861579265.USD","LU0106261372.USD","LU0070302665.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0208291251.USD","LU2433249047.HKD","SG9999014559.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125909247.SGD","BK4533","LU1035773651.USD","LU1093756168.USD","HRTS","LU0320765646.SGD","LU0689626769.HKD","LU0238689110.USD","LU1934455194.USD","LU1201861249.SGD","LU1430594728.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0320765489.SGD","MRK","IE000M9KFDE8.USD","LU0289739699.SGD","LU0211331839.USD","LU1923622614.USD","LU1974910355.USD","LU0859254822.USD","LU0965508806.USD","LU1917777945.USD","LU0265550946.USD","IXJ","LU1934455277.USD","SG9999001176.USD","LU2125909593.SGD","LU2125154935.USD","LU0511384066.AUD","LU1571399168.USD","IE00BJT1NW94.SGD","TRUH","LU0648001328.SGD","SG9999015341.SGD","LU0432979614.USD","LU0942090050.USD","IE00B2B36J28.USD","LU0130102774.USD","LU2125154778.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","LU0980610538.SGD","LU2112291526.USD","LU0098860793.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","PAWZ","LU0122379950.USD","IE00BBT3K403.USD","LU0057025933.USD","SG9999002232.USD","JDOC","LU2106854487.HKD","LU2089984988.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","SG9999015358.SGD","BMED","LU0006306889.USD","LU0868494708.USD","SG9999002224.SGD","IYH","LU1066053197.SGD","LU1989772840.SGD","LU1037948541.HKD","LU0965509283.SGD","IE00BLSP4239.USD","LU0868494617.USD","IHE","LU1929549753.HKD","BK4007","IE00BN8TJ469.HKD","LU0472753341.HKD","LU1066051225.USD","LU2491050071.SGD","LU0130517989.USD","FHLC","LU1023059063.AUD","LU0965509010.AUD","LU1983299246.USD","LU0203345920.USD","LU1699723380.USD","LU0477156953.USD","LU2361044949.HKD","LU1066051498.USD","LU1116320737.USD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670570239","title":"Merck & Co - to Record $400 Mln Pre-Tax Charge, $0.13 Per Share, in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670570239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670570239?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:45","pubTimestamp":1790592300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUABQXML8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRK","BK4516","LU1116320901.HKD","BK4585","LU1037948897.HKD","LU0265550946.USD","LU2357627491.SGD","LU2361045086.USD","LU1934455863.HKD","BK4588","LU0320765646.SGD","LU0432979614.USD","LU0965508806.USD","PPH","LU0266013472.USD","LU1983299246.USD","LU1061106388.HKD","LU1066051811.HKD","LU2089984988.USD","IE00BLSP4452.SGD","LU0823416689.USD","LU0965509010.AUD","LU2112291526.USD","LU1057294990.SGD","BMED","LU0265550359.USD","FHLC","SG9999014567.USD","TRUH","LU0057025933.USD","LU0289739699.SGD","LU0477156953.USD","LU1941712264.USD","IYH","LU0868494617.USD","LU2106854487.HKD","SG9999013999.USD","FTXH","LU0942090050.USD","LU1923622614.USD","LU0289961442.SGD","BK4559","LU1917777945.USD","LU2360032135.SGD","LU1032466523.USD","LU1699723380.USD","LU2125154778.USD","SG9999015341.SGD","JDOC","LU1201861249.SGD","LU1093756325.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1066051225.USD","LU2491049909.HKD","LU0472753341.HKD","LU2433249047.HKD","RXL","LU1093756168.USD","IE00BLSP4239.USD","LU0985320562.USD","SGXZ57979304.SGD","LU0069063385.USD","LU1066053197.SGD","IE0009355771.USD","LU2491050071.SGD","GDOC","BK4550","LU1989771016.USD","LU1430594728.SGD","LU2125909247.SGD","LU2023250843.SGD","LU0006306889.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0868494708.USD","LU1162221912.USD","LU2461242641.AUD","LU1989772923.USD","BK4534","LU1023059063.AUD","LU0511384066.AUD","XLV","LU0965509101.SGD","LU1989772840.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","SG9999002232.USD","SG9999014542.SGD","LU2468319806.SGD","PAWZ","SG9999014575.USD","LU1934455194.USD","LU2125909593.SGD","IXJ","IE00BFTCPJ56.SGD","LU1941712348.USD","LU1934455277.USD","LU0098860793.USD","LU1066051498.USD","SG9999015358.SGD","LU2324357040.USD","LU0106261372.USD","LU2125154935.USD","BK4533","LU0203347892.USD","LU0980610538.SGD","SG9999001176.USD","IHE","LU0058720904.USD","LU0124676726.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0859254822.USD","LU0861579265.USD","VHT","LU0320765489.SGD","SG9999014559.SGD","LU1037948541.HKD","BK4007","LU0072461881.USD","LU0211331839.USD","LU1291159041.SGD","SG9999001440.SGD","SG9999002224.SGD","LU0689626769.HKD","LU0130102774.USD","LU0122379950.USD","LU0648001328.SGD","LU0130517989.USD","LU1974910355.USD","LU0070302665.USD","LU0238689110.USD","LU0289739343.SGD","LU1929549753.HKD","HRTS","IE0002141913.USD","LU0162691827.USD","LU0203345920.USD","LU1069347547.HKD","LU1035773651.USD","LU2023250504.SGD","LU1585245621.USD","LU2491050154.USD","LU2361044949.HKD","LU1116320737.USD","IE00BN8TJ469.HKD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670505239","title":"Merck & Co - Deal Includes $400 Mln Upfront, Total Potential Value $2.13 Bln; Deal Closed","url":"https://stock-news.laohu8.com/highlight/detail?id=2670505239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670505239?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:45","pubTimestamp":1790592300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUABQXML8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","LU1057294990.SGD","SG9999002232.USD","MRK","LU1291159041.SGD","BK4559","BMED","SG9999001440.SGD","LU1983299246.USD","LU0208291251.USD","IE00BLSP4239.USD","LU0861579265.USD","LU2361044865.SGD","LU1430594728.SGD","LU2324357040.USD","LU0238689110.USD","LU1989771016.USD","LU1066051811.HKD","LU0965508806.USD","LU0203345920.USD","LU1061106388.HKD","LU0265550359.USD","LU1923622614.USD","BK4534","LU0266013472.USD","LU0985320562.USD","LU0320765646.SGD","LU1571399168.USD","LU2461242641.AUD","LU0980610538.SGD","LU1066053197.SGD","LU0234572021.USD","LU1037948897.HKD","LU2125909247.SGD","LU0689626769.HKD","LU0942090050.USD","LU0823416689.USD","LU2023250504.SGD","LU1929549753.HKD","LU1093756168.USD","LU2106854487.HKD","LU0472753341.HKD","LU0868494708.USD","LU0965509010.AUD","LU0057025933.USD","PAWZ","LU1066051498.USD","BK4516","LU0006306889.USD","FTXH","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU0289739343.SGD","LU1585245621.USD","LU2089984988.USD","JDOC","SG9999002224.SGD","LU1989772840.SGD","LU1941712264.USD","LU2361045086.USD","IE00BSNM7G36.USD","LU2023250843.SGD","LU1974910355.USD","LU0965509101.SGD","LU0130102774.USD","IE00BN8TJ469.HKD","SG9999015358.SGD","SG9999014542.SGD","LU1934455863.HKD","LU0211331839.USD","LU0289739699.SGD","LU2125154935.USD","IYH","LU1093756325.SGD","LU1116320737.USD","LU2125909593.SGD","LU0432979614.USD","HRTS","SG9999014575.USD","LU1201861249.SGD","XLV","LU1989772923.USD","RXL","LU0868494617.USD","LU0162691827.USD","LU1917777945.USD","LU0072461881.USD","SG9999013999.USD","LU0069063385.USD","LU2491049909.HKD","IE00B1BXHZ80.USD","SG9999001176.SGD","LU0058720904.USD","LU0265550946.USD","LU1934455277.USD","IE00BBT3K403.USD","LU2468319806.SGD","LU1941712348.USD","TRUH","LU0477156953.USD","IE0009355771.USD","BK4550","IXJ","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0124676726.USD","SG9999014559.SGD","SG9999014567.USD","SGXZ57979304.SGD","SG9999015341.SGD","LU1069347547.HKD","LU1934455194.USD","BK4588","LU0965509283.SGD","LU1066051225.USD","LU1162221912.USD","LU0289961442.SGD","LU2360032135.SGD","LU1037948541.HKD","SG9999001176.USD","GDOC","LU1699723380.USD","FHLC","LU0859254822.USD","LU1032466523.USD","LU0203347892.USD","LU2357627491.SGD","BK4007","BK4533","LU0122379950.USD","LU2491050071.SGD","LU0130517989.USD","LU1116320901.HKD","LU1023059063.AUD","LU2361044949.HKD","LU2125154778.USD","LU0320765489.SGD","VHT","LU0648001328.SGD","IE00BLSP4452.SGD","IHE","LU2491050154.USD","PPH","LU2433249047.HKD","BK4585","LU0511384066.AUD","LU1035773651.USD","IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","LU0098860793.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239696","title":"Merck & Co Inc: Under Agreement, Scibrunch Granted Co Exclusive Rights to Develop, Manufacture & Commercialize Spr2015 Worldwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239696?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:45","pubTimestamp":1790592300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUABQXML8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BN8TJ469.HKD","LU2125154778.USD","BK4534","LU0965509283.SGD","LU2023250843.SGD","LU0072461881.USD","LU2491050154.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0320765646.SGD","IE00BBT3K403.USD","BK4516","LU0823416689.USD","LU0648001328.SGD","LU1093756168.USD","LU1974910355.USD","LU0265550359.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","SG9999013999.USD","SG9999001176.SGD","LU0868494617.USD","LU0162691827.USD","SGXZ57979304.SGD","LU2491050071.SGD","LU2357627491.SGD","LU0266013472.USD","LU1066051498.USD","LU0985320562.USD","SG9999002232.USD","LU0106261372.USD","LU2106854487.HKD","LU2125909593.SGD","FHLC","LU1116320901.HKD","LU1066051225.USD","LU1037948541.HKD","LU0130102774.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1162221912.USD","LU1571399168.USD","TRUH","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1934455194.USD","LU0432979614.USD","VHT","LU0965509010.AUD","BK4550","IE000M9KFDE8.USD","LU0859254822.USD","LU1941712348.USD","IHE","LU0265550946.USD","LU0965509101.SGD","LU1057294990.SGD","LU1585245621.USD","LU1066051811.HKD","LU0861579265.USD","LU0203345920.USD","SG9999001176.USD","LU0289961442.SGD","SG9999015341.SGD","LU0122379950.USD","PAWZ","LU1035773651.USD","LU0124676726.USD","LU0069063385.USD","BK4588","LU1989772840.SGD","LU0057025933.USD","IE00BSNM7G36.USD","LU1023059063.AUD","IE0009355771.USD","JDOC","IE00B2B36J28.USD","LU2468319806.SGD","LU1037948897.HKD","MRK","LU2023250504.SGD","LU2125154935.USD","LU0238689110.USD","IE00BLSP4452.SGD","LU0208291251.USD","LU0689626769.HKD","SG9999014575.USD","LU1291159041.SGD","LU1923622614.USD","LU0965508806.USD","LU2361044865.SGD","LU1983299246.USD","LU2360032135.SGD","LU0289739699.SGD","SG9999014542.SGD","HRTS","LU0006306889.USD","IXJ","LU1929549753.HKD","LU2089984988.USD","LU1066053197.SGD","LU0477156953.USD","IE00BJT1NW94.SGD","LU0211331839.USD","LU0980610538.SGD","LU0289739343.SGD","LU0868494708.USD","LU1069347547.HKD","LU2361045086.USD","SG9999014567.USD","XLV","LU1032466523.USD","LU2433249047.HKD","GDOC","LU2112291526.USD","LU1201861249.SGD","LU1941712264.USD","LU1093756325.SGD","LU0472753341.HKD","RXL","LU0511384066.AUD","BK4585","LU2324357040.USD","LU2491049909.HKD","FTXH","BMED","SG9999001440.SGD","IYH","LU0130517989.USD","IE0002141913.USD","LU0320765489.SGD","LU1699723380.USD","SG9999015358.SGD","LU0058720904.USD","LU1934455863.HKD","BK4533","LU1116320737.USD","LU1061106388.HKD","BK4007","LU0070302665.USD","LU2361044949.HKD","PPH","LU2125909247.SGD","BK4559","LU1917777945.USD","LU1430594728.SGD","SG9999002224.SGD","SG9999014559.SGD","LU1934455277.USD","LU1989771016.USD","LU1989772923.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH","BMED","MRNX","TECB","MEDI","GDOC","GNMX","LABU","LFSC","IYH","MRNY","BK4007","BK4588","NVIB","FRTY","IDNA","XLVX","BBP","PSCH","IEIH","SYNB","RSPH","PINK","IBB","BK4585","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109891748","title":"Sun-Novo Pharmaceutical's STC008 Injection Meets Expected Goals in Phase I Trial for Cancer Cachexia in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1109891748","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109891748?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:08","pubTimestamp":1790590125,"startTime":"0","endTime":"0","summary":"Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. (688621.SH) has announced that its wholly-owned subsidiary, Chengdu Novo-St Biotechnology Co., Ltd. (\"Novo-St\"), has achieved the expected objectives...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","IBBJ","MDTX","IBBQ","PSYK","688621","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136095749","title":"Betta Pharmaceuticals (300558.SZ): BPI-572270 Capsules Approved for Clinical Trials in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1136095749","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136095749?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:32","pubTimestamp":1790587955,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co.,Ltd. (300558.SZ) has announced that its wholly-owned subsidiary, Hangzhou Jingyao Biotechnology Co., Ltd. (\"Jingyao Biotech\"), has received approval from Australia's Human...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","MDTX","BK0239","300558","PSYK","IBBQ","BK0060","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119593670","title":"Wuhan Hiteck Biological Pharma Secures Clinical Trial Approval for Epranemide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1119593670","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119593670?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:26","pubTimestamp":1790587580,"startTime":"0","endTime":"0","summary":"Wuhan Hiteck Biological Pharma Co.,Ltd. (300683.SZ) has announced that the company recently received a Drug Clinical Trial Approval Notice issued by the National Medical Products Administration.The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300683","BMED","BK0239","IBBJ","PSYK","MDTX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112995199","title":"Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1112995199","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112995199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:10","pubTimestamp":1790586629,"startTime":"0","endTime":"0","summary":"Dezhan Healthcare Company Limited (000813.SZ) has announced that its wholly-owned subsidiary, Beijing Honghui Xin Pharmaceutical Technology Co., Ltd., recently received notification from the U.S....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0114","000813","BK1574","PSYK","IBBQ","BK4585","BMED","BK4588","MDTX","06978","IBBJ","LABU","MEDX","159992","BK0239","LNGR","BK1161","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195604847","title":"Merck's Keytruda Subcutaneous Formulation Approved for Launch in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1195604847","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195604847?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:38","pubTimestamp":1790584732,"startTime":"0","endTime":"0","summary":"The National Medical Products Administration (NMPA) official website indicated on September 28 that Merck's pembrolizumab injection (subcutaneous injection, namely MK-3475A) has been approved for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU0965509283.SGD","LU0266013472.USD","LU0511384066.AUD","IE00BBT3K403.USD","IXJ","LU0432979614.USD","LU1116320901.HKD","LU2324357040.USD","LU1037948897.HKD","LU0098860793.USD","LU0823416689.USD","LU1116320737.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE0002141913.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0162691827.USD","LU1162221912.USD","SG9999001176.SGD","LU0289739699.SGD","LU2491049909.HKD","BK4585","BMED","IE00BJT1NW94.SGD","LU1974910355.USD","LU1035773651.USD","LU1023059063.AUD","LU0211331839.USD","LU0942090050.USD","LU0689626769.HKD","LU0203345920.USD","BK4007","LU1066053197.SGD","LU1934455194.USD","LU0289961442.SGD","LU0868494617.USD","IYH","LU2361044949.HKD","LU0861579265.USD","LU1061106388.HKD","LU1934455277.USD","LU0320765646.SGD","LU2106854487.HKD","SG9999014542.SGD","LU2361045086.USD","SG9999013999.USD","JDOC","LU0070302665.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","GDOC","LU1941712264.USD","VHT","LU2112291526.USD","BK4516","IE00B2B36J28.USD","LU0069063385.USD","LU0057025933.USD","IE0009355771.USD","TRUH","LU0234572021.USD","BK4588","LU0980610538.SGD","LU0006306889.USD","LU1066051498.USD","SG9999014575.USD","HRTS","LU0320765489.SGD","LU1430594728.SGD","LU1093756168.USD","SG9999001176.USD","LU2125154935.USD","LU0130517989.USD","LU0203347892.USD","LU1093756325.SGD","LU2491050071.SGD","LU1934455863.HKD","LU0122379950.USD","IE00BLSP4452.SGD","LU1066051225.USD","LU1057294990.SGD","LU0477156953.USD","LU0238689110.USD","LU2360032135.SGD","LU1923622614.USD","LU2023250843.SGD","LU1037948541.HKD","SG9999001440.SGD","LU1201861249.SGD","SG9999014567.USD","LU0265550359.USD","LU1699723380.USD","LU0472753341.HKD","LU2461242641.AUD","LU2125154778.USD","FTXH","LU1032466523.USD","LU0965509101.SGD","LU2468319806.SGD","LU1571399168.USD","LU1585245621.USD","SG9999014559.SGD","SG9999002224.SGD","FHLC","LU0124676726.USD","LU0058720904.USD","LU2491050154.USD","MRK","IE000M9KFDE8.USD","BK4534","IE00BLSP4239.USD","LU2433249047.HKD","LU0648001328.SGD","LU1917777945.USD","LU2089984988.USD","LU0289739343.SGD","PPH","LU0965509010.AUD","RXL","LU0868494708.USD","LU1929549753.HKD","LU1989772923.USD","LU1989771016.USD","LU2125909593.SGD","PAWZ","LU1066051811.HKD","LU1941712348.USD","IHE","IE00BFTCPJ56.SGD","LU2361044865.SGD","LU0859254822.USD","LU2357627491.SGD","LU0265550946.USD","BK4533","LU2125909247.SGD","SG9999002232.USD","XLV","BK4550","LU0072461881.USD","LU0985320562.USD","LU0965508806.USD","LU1983299246.USD","LU2023250504.SGD","IE00BN8TJ469.HKD","LU0106261372.USD","LU1989772840.SGD","SG9999015358.SGD","LU0208291251.USD","SG9999015341.SGD","LU0130102774.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280899","title":"Ingenia Therapeutics Expects USD 5 Million MK-8748 Milestone Payment from Merck Unit Eyebiotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670280899?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:32","pubTimestamp":1790584375,"startTime":"0","endTime":"0","summary":"Ingenia Therapeutics expects USD 5 million MK-8748 milestone payment from Merck unit EyebiotechIngenia Therapeutics expects to receive a milestone payment tied to MK-8748, licensed to Merck unit Eyebi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL1wFv0s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU2023250504.SGD","FHLC","LU1201861249.SGD","LU1989772840.SGD","LU0985320562.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU0320765489.SGD","LU1923622614.USD","LU0265550359.USD","VHT","LU0965509010.AUD","LU0868494617.USD","XLV","IHE","LU0130517989.USD","LU2089984988.USD","LU0289739699.SGD","LU2023250843.SGD","LU0124676726.USD","LU0072461881.USD","SG9999014559.SGD","IE00B2B36J28.USD","LU1162221912.USD","BK4516","IE00BLSP4452.SGD","LU1699723380.USD","BMED","LU1116320737.USD","IE0002141913.USD","LU1941712264.USD","LU0098860793.USD","LU2433249047.HKD","PAWZ","LU0058720904.USD","IE00BN8TJ469.HKD","RXL","LU1934455277.USD","LU1061106388.HKD","LU0472753341.HKD","LU0057025933.USD","LU0477156953.USD","LU2491050071.SGD","SG9999015358.SGD","LU0266013472.USD","LU1929549753.HKD","LU1291159041.SGD","LU1571399168.USD","LU2324357040.USD","SG9999001176.SGD","SG9999014567.USD","IE00BFTCPJ56.SGD","LU1934455863.HKD","LU2357627491.SGD","LU2125154778.USD","SG9999001440.SGD","LU1069347547.HKD","LU1066053197.SGD","LU1983299246.USD","BK4585","LU1093756325.SGD","LU2125909247.SGD","TRUH","BK4533","LU0689626769.HKD","SG9999001176.USD","LU2112291526.USD","BK4534","LU0265550946.USD","LU0980610538.SGD","SG9999015341.SGD","LU1974910355.USD","LU0006306889.USD","LU0122379950.USD","LU0238689110.USD","LU1917777945.USD","LU1989771016.USD","IE000M9KFDE8.USD","LU2491049909.HKD","SG9999014575.USD","LU0208291251.USD","LU0965508806.USD","LU1585245621.USD","LU0648001328.SGD","LU1057294990.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","IE0009355771.USD","LU2361045086.USD","LU1093756168.USD","IE00BBT3K403.USD","LU0861579265.USD","LU0289961442.SGD","FTXH","LU2125909593.SGD","LU2461242641.AUD","LU0106261372.USD","LU0162691827.USD","GDOC","LU0320765646.SGD","LU1037948541.HKD","IE00BSNM7G36.USD","IYH","MRK","LU0070302665.USD","LU0234572021.USD","BK4588","LU0289739343.SGD","LU0965509283.SGD","LU0942090050.USD","SG9999013999.USD","LU0211331839.USD","LU2361044949.HKD","LU0859254822.USD","HRTS","LU2468319806.SGD","BK4007","IXJ","LU1023059063.AUD","BK4559","LU1035773651.USD","LU1066051811.HKD","LU0868494708.USD","LU2106854487.HKD","LU2360032135.SGD","LU0203347892.USD","JDOC","LU1430594728.SGD","LU0965509101.SGD","LU1032466523.USD","IE00BLSP4239.USD","LU0069063385.USD","SG9999002224.SGD","LU0203345920.USD","LU0432979614.USD","LU2491050154.USD","PPH","LU2361044865.SGD","SG9999002232.USD","LU0130102774.USD","LU1066051498.USD","SG9999014542.SGD","LU1116320901.HKD","LU2125154935.USD","LU1066051225.USD","LU1941712348.USD","LU0511384066.AUD","BK4550","LU1934455194.USD","IE00BJT1NW94.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","EES","PSCH","FRTY","GDOC","IDNA","MRNX","BMED","IYH","XLVX","BK4588","LABU","BBP","TECB","GNMX","TBXU","SYNB","NVIB","IBB","LFSC","IEIH","BK4585","MRNY","RSPH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197962641","title":"Sichuan Biokin Pharmaceutical Receives Clinical Trial Approval for Injectable BL-M12D1 (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1197962641","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197962641?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:26","pubTimestamp":1790508369,"startTime":"0","endTime":"0","summary":"Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SH) has announced that the company recently received the official Drug Clinical Trial Approval Notice issued by the National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BMED","IBBJ","IBBQ","BK4231","BK4080","ADC","MDTX","688506","NETL","BK0239","91194"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":6,"totalSize":224,"code":"91000000","status":"200"}]}}